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Determination of Important Ligand Sites for the Interaction with Aminoglycoside
Acetyltransferase (3)
(3)-IIIb by NMR
The most prevalent cause of resistance to antibiotics is due to the emergence of
bacterial enzymes with the ability to modify and thus deactivate these drugs. Aminoglycosides
are a large class of antibiotics that have become particularly susceptible to enzymatic
modification, which leads to decreased bactericidal effects. Aminoglycosides normally exert
their bactericidal effects by binding to the small ribosomal subunit, more specifically the tRNA
acceptor A site of the 16S ribosomal subunit
subunit, and thus disrupting translation by incorporation of
the wrong amino acid into the newly synth
synthesized
esized protein or by premature termination of
protein synthesis. However, covalent modificatio
modification
n of the antibiotic lowers its affinity to the
ribosome so that protein
ein synthesis continues unaffected
unaffected. Inactivation of aminoglycosides by
means of enzymatic covalent
alent modification is catalyzed by a wide variety of bacterial enzymes
that are classified into three groups: acetyltransferases, nucleotidyltransferases, and
phosphotransferases (Magnet and Blanchard 2005
2005).

Figure 1. Acetylation of
the N-3
3 position of
aminoglycosides is
catalyzed by AAC3.
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Most of the bacterial enzymes that catalyze these modifications are promiscuous among
aminoglycoside antibiotics and have the capability of modifying many different aminoglycosides
at structurally similar and unique sites ((Owston and Serpersu 2002).
). Within each family of
aminoglycoside-modifying
modifying enzymes are members with different modification sites as indicated
by the number in parentheses (Magnet and Blanchard 2005
2005).
). The enzyme of interest in this
study is aminoglycoside acetyltransferase (3)-IIIb (AAC3),, which is responsible for the acetylacetyl
CoA-dependent N-acetylation
acetylation of the amine group at carbon 3 of the 22-DOS
DOS ring of
paromomycin and other typical aminoglycosides as shown in Figure 1 (Owston
Owston and Serpersu
2002).
). This enzyme belongs to one of the largest families of acetyltransferases, which further
consists of four groups, I-IV,
IV, classified by the type of resistance conferred (Magnet and
Blanchard 2005). Since the 3-NH
NH2 site is common to all aminoglycosides and
nd modification of
this site decreases drug efficacy, this enzyme is of particular interest for studying the
modification of typical antibiotics (Norris et. al. 2010
2010). Accordingly, determination of which
ligand sites interact with AAC3 could be valuable iinformation
nformation for drug designers involved in the
continuous warfare on antibiotic resistance, possibly through the development of enzyme
inhibitors and/or synthetic antibiotics (Yu et. al. 2006, Hanessian et. al. 2006).
Figure 2.
2
Structures of three
neomycin-class
neomyci
aminoglycosides.
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Paromomycin is the aminoglycoside chosen for this study because of its thermodynamic
and kinetic properties relative to AAC3. An aminoglycoside with a fast exchange rate and a 1:1
stoichiometric ratio is preferred for this type of analysis so that data can be acquired from the
enzyme-bound ligand. Paromomycin belongs to the neomycin-class of aminoglycosides, which
are characterized by a 2-deoxystreptamine (2-DOS) ring that is 4, 5-disubstituted, as shown in
Figure 2 (Magnet and Blanchard 2005). Although, the resonance assignments for many
aminoglycosides, including neomycin B, are available, those of paromomycin are not. Also, the
only other member of this class that binds to AAC3 with a 1:1 stoichiometry is neomycin B.
However, neomycin B has a very small KD value and thus binds tightly with AAC3, but
paromomycin has a substantially higher KD value of 9.2 ± 0.4µM for the binary complex and 1.5
± 0.3µM for the ternary complex (Norris et. al. 2010). These properties of paromomycin may
allow for a fast exchange-rate of the enzyme-ligand complex, which is necessary to obtain the
NMR data.
For this project, AAC3 will be overexpressed in E. coli and purified for use in
these experiments and NMR-based analysis will be utilized to identify the sites on paromomycin
that are interacting with AAC3. Initially, the resonance assignments for free paromomycin will
be determined by NMR (Nuclear Magnetic Resonance) using 1H-1H TOCSY (TOtal Correlation
SpectroscopY) and 13C-1H HSQC (Heteronuclear Single Quantum Coherence). These experiments
will provide resonance assignments which are necessary to determine which ligand sites are
interacting with the enzyme.
Decoupled 13C-1H HSQC spectra will be acquired under standard conditions for free
paromomycin and for paromomycin in the presence of AAC so that the changes in position of
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each peak can be measured (chemical shift mapping). Shifts will occur for the carbons adjacent
to those sites on the ligand that are directly interacting with the enzyme. Additionally,
undecoupled 13C-1H HSQC spectra will be used to measure the change in coupling constants for
a sample of paromomycin in the presence and absence of AAC3. The 13C-1H couplings for those
carbons adjacent to an amine substituent are of particular interest because the coupling
constant varies proportionally to the protonation state of the adjacent amine group. From this
measurement, the differences in pKa’s of amines in the free and enzyme-bound states can be
observed. These results will be used to identify which sites on the ligand are interacting with
the enzyme as seen by the change in chemical shift of the corresponding carbon.
Resonance Assignments of Paromomycin Spectrum
The structure of paromomycin is shown in Figure 3 along with the numbering system of
the molecule. In order to use this aminoglycoside as a substrate for AAC3 in NMR experiments,
the resonance assignments for free paromomycin needed to be made first.

Figure 3. Paromomycin consists of two hexose
rings (rings I and IV), one pentose ring (ring III), and
the deoxystreptamine ring (ring II).

The 1H and 13C resonance assignments for free paromomycin were made using twodimensional 1H-13C heteronuclear single quantum coherence (HSQC) and 1H-1H total correlation

Woodruff 5

spectroscopy (TOCSY). Two-dimensional
dimensional spectroscopy correlates two frequencies, which can
either be homonuclear or heteronuclear. As seen in the example in Figures 4 and 5,
5 twodimensional homonuclear spectra have peaks that line
ne up in a diagonal because the two
frequencies are correlated with each other
other,, while heteronuclear spectra correlate the
frequencies from two different nuclei
nuclei. Since paromomycin is a large compound consisting
con
of
four sugar rings, one-dimensional
dimensional and even two
two-dimensional
dimensional homonuclear spectra were too
crowded to assign all of the peaks
peaks; therefore, two-dimensional 1H-13C HSCQ provided an
a
unambiguous spectra with non-overlapping
overlapping peaks.

Figure 4. The H-H correlated 2-D
D spectrum of ethyl
benzene shows the diagonal cross-peaks
peaks that result from
homonuclear TOCSY experiments. (Image: JP Hornak,
Basics of NMR, 1997-2002)

Figure 5. C-H correlated 2-D spectrum of biturosin, an
aminoglycoside. The 1-D carbon
n and proton spectra are
shown above and to the left of the 2-D
D spectrum,
spectrum
respectively. (Image: unpublished data from Dr.
Serpersu’s lab)
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Figure 6. Magnetization evolves in the 1’  2’ direction
because the oxygen prevents it from evolving in the 1’  5’
direction during TOCSY experiments.

The TOCSY experiments generate spectra with diagonal cross-peaks
peaks between all spins in
a coupled system; furthermore, this method is especially useful for evaluating large molecules
with sugar rings (Sanders and Hunter 1993)
1993). As shown in Figure 6,, magnetization evolves
unidirectionally around the ring beginning at the anomeric proton whe
when the magnetic field is
applied for a certain amount of time, called mixing time. This effect occurs
urs because
magnetization must travel from proton to proton and the oxygen atom in the ring, which has no
hydrogen atoms attached, acts as a road block for the traveling magnetization.. As mixing time
increases, the spins on that ring system become strongly coupled due to the spin-locking
spin
field.
When
hen the applied magnetic field is removed and magnetization return
returns to its original state,
each proton expresses the precession frequency of all other spins in the coupled system
resulting in cross-peaks (Sanders and Hunter 199
1993). Therefore, by collecting TOCSY spectra
with various mixing times ranging from 15ms to 80ms, most of the proton chemical shifts could
be made for paromomycin.
Model aminoglycosides provided important clues in the assignment of the paromomycin
spectrum because of the similarities at certain sites on these ligands. The resonance
assignments for neomycin B (Reid
Reid and Gajjar 1987) were taken into consideration while making
these resonance assignments, since paromomycin differs from neomycin B by only one
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substituent with an hydroxyl group replacing an amine group at the C-6’ position in
paromomycin (Figure 2). Other aminoglycosides, such as ribostamycin and kanamycin A, were
useful as model structures because of their similarity to paromomycin, although they consist of
only three rings. In order to make the 1H resonance assignments for paromomycin, the most
widely conserved and most recognizable positions among model structures, the anomeric
protons and the 2-axial and 2-equatorial protons, served as starting points for this task. After
identifying the three anomeric protons, the remaining assignments were made by following the
connectivities around the ring system that appear as mixing time increases.
Similar to neomycin B and other model structures, the three anomeric protons (1’ at
5.52 ppm, 1’’ at 5.39 ppm, and 1’’’ at 5.13 ppm) are located furthest downfield and diagonal
cross-peaks can be seen between protons on the same ring system as mixing time increases,
while the two signals furthest upfield belong to H-2a and H-2e due of their electromagnetic
environment (Reid and Gajjar 1987). Also, the number of connectivities to the anomeric
carbons and the chemical shifts of individual protons on each ring provide a way to determine
the specific assignment of each anomeric peak. For example, ring III contains one less carbon
atom than the other rings, which results in one less connectivity to the H-1’’ proton.
Furthermore, the resonance peak for H-2’ is the furthest upfield connectivity to an anomeric
proton while that of H-2’’’ is the next most upfield connectivity to a different anomeric proton
according to the expected chemical shifts for these protons next to amine groups and the
resonance assignments of neomycin B. As shown in Figures 7 and 8, the first cross-peaks to
develop at the shortest mixing time (15ms) are those between H-1’ and H-2’ (3.01 ppm) and H1’’ and H-2’’ (4.34 ppm) and the number of cross-peaks to develop increases with mixing time.
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Figure 9 shows labeled cross-peaks along the diagonal of the two-dimensional 1H-1H TOCSY
spectrum for pure paromomycin in D2O with the longest mixing time (80ms).

Figure 7. The 2-D TOCSY
spectrum of
paromomycin with 15ms
mixing time shows that
the first connectivities to
appear are those
between H-2’ (3.01 ppm)
and H-2’’ (4.34ppm).

Figure 8. The number of
cross-peaks increases with
mixing time as shown in
the 2-D TOCSY spectrum of
paromomycin with 60ms
mixing time.
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Figure 9 . The 2-D 1H-1H TOCSY spectrum of paromomycin with 80ms mixing time is labeled
with the position of the proton connectivities to the anomeric protons.

The deoxystreptamine ring presents more of a challenge to assign than the other three
rings because magnetization can travel in both directions around this ring and because this ring
is very symmetrical. As also reported for neomycin B and tobramycin, this ring contains two
protons, H- 1 and H-3, with almost exactly the same chemical shift due to the nature of their
positions on this ring (Reid and Gajjar 1987, Van Pelt 1990). For crowded regions such as 3.703.78 ppm, the 1H-13C HSQC spectrum separated these overlapping peaks and made assigning
these resonances possible. However, this method did not help decipher between the H-1 and
H-3 proton shifts because they also have almost identical carbon shifts, which results in a
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conjoined resonance peak. The 1H-13C HSQC decoupled spectrum is shown in Figure 10 and the
proton and carbon resonance assignments are shown in Table I. All of the peaks were assigned
and all C-H couplings were accounted for, which is expected from a pure sample of
paromomycin in D2O.
Table I
Proton
Ring I
1
2ax
2eq
3
4
5
6
Ring II
1’
2’
3’
4’
5’
6’
RingIII
1’’
2’’
3’’
4’’
5’’a
5’’b
Ring IV
1’’’
2’’’
3’’’
4’’’
5’’’
6’’’a,b

1

H δ(ppm)

13

C δ(ppm)

3.05
1.43
2.15
3.05
3.59
3.78
3.50

51.25
33.41
33.41
50.48
82.57
85.29
75.46

5.52
3.01
3.74
3.46
3.86
3.70

98.97
55.76
72.39
70.54
73.82
60.97

5.39
4.34
4.51
4.19
3.91
3.79

109.90
74.37
75.99
82.08
61.23
61.23

5.13
3.26
4.13
3.76
4.24
3.34

98.44
52.45
70.00
85.29
71.67
41.54

Figure 10. The 1H-13C HSQC spectrum of a pure
sample of 4.75mM paromomycin in D2O is labeled
with peak assignments.
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After making the resonance assignments for free paromomycin in D2O, 1H-13C HSQC
decoupled and undecoupled spectra were obtained for a sample of free paromomycin under
standard conditions, which contained 2mM paromomycin, 100mM NaCl, 1mM Tris-HCl
Tris
and 20%
D2O at pH 7.6 and for a sample under the same conditions with the addition of 45µM AAC3.
From the decoupled spectra,, it was possible to follow which resonance peaks move position or
change in intensity upon interaction with the enzyme. As seen in Figure 11,, three of the
protons interacting with AAC3 (H
(H-2 equatorial, H-2 axial, and H-6)
6) are in the vicinity of the N-3
N
acetylation site on the deoxystreptamine ring, while the other th
three
ree protons interacting with
the enzyme (H-2’, H-2’’’, and H-5’’’)
5’’’) are located on the outer rings of the aminoglycoside. Peaks
that shifted by 0.03 ppm
m or more were consider a significant change resulting from interaction
with AAC3 and the findings are listed in Table II. Due to overlap of the peaks of H-1
H and H-3,
the changes in these chemical shift
shifts were unable to be quantitatively determined; however,
howeve
there is an obvious change in the size and shape of this conjoined peak as shown in Figures 12
and 13. Also, the H-6’ peak,, which was of interest because that is the only site that is different
between paromomycin and neomycin B, was hidden by the peak belonging to the buffer, TrisHCl. The resonance peaks for H--2 axial and H-2
2 equatorial are significantly lower in signal
strength when AAC is present but their resonances were still able to be measured once the
contour levels were raised.

he structure of paromomycin is labeled with
Figure 11. The
the protons that correspond to the peaks that shifted
greater than 0.03ppm upon addition of AAC.
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Table II
Proton
H-2e
H-2a
H-6
H-2’
H-2’’’
H-5’’’

Table III
1

Shift in H δ
(ppm)
0.03
0.05
0.05
0.03
0.04
0.03

Proton

1

Change in H-13C coupling constants (Hz)

H-1

-8.13

H-3

+5.91

H-2’’’

+3.85

Figure 12. The 2--D 1H-13C HSQC
decoupled spectrum of 2mM
paromomycin under standard
conditions with an arrow pointing
to the position of the H-1
H and H-3
peaks.

Figure 13. The 2--D 1H-13C HSQC
decoupled spectrum of 2mM
paromomycin and 45µM AAC
under standard conditions.
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The coupling constants were measured for both of the undecoupled 1H-13C HSQC
spectra for paromomycin and compared in order to elucidate any changes in coupling constants
upon addition of the enzyme to the sample. For the undecoupled 1H-13C HSQC spectra, each
carbon resonance has two corresponding proton resonances and the distance between these
two proton peaks is referred to as the coupling constant. As mentioned earlier, a change in the
coupling constant varies proportionally with the protonation state of an adjacent amine group.
It is assumed that there is a small error of measure and therefore only changes in coupling
constants greater than 3.0 Hz were considered to be a result of a significant a change in the
environment of the proton. There were three amine groups, N-1, N-3, and N-2’’’, that showed
variation in their protonation state as determined by the changes in coupling constants of
adjacent protons (Table III). However, these changes in coupling constants differed in
magnitude and direction upon interaction with AAC3. For H-3 and H-2’’’, the coupling
constants increased by 5.91 Hz and 3.85 Hz, respectively, but the coupling constants for H-1
decreased by 8.13 Hz. These differences are caused by the uptake and release of protons by
the adjacent amine groups, respectively. It is likely that the amine group at N-1 is experience a
loss of positive charge which corresponds to the decrease in the coupling constant of H-1.
These differences in coupling constant changes may be due to the amine groups at N-3 and
N-2’’’ having the lowest pKa values of the five amine groups (Barbieri and Pilch 2006).
When the same NMR experiments were collected for a sample of neomycin B under
standard conditions in the presence and absence of AAC3, the findings were similar to those of
paromomycin for changes in proton chemical shifts. As with paromomycin, the H-2 axial, H-6,
H-2’ and H-2’’’ peaks shifted in the proton dimension by 0.03 ppm or more; however, for
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neomycin B, the H-1 and H-1’’’ peaks shifted rather than the H-2 equatorial and H-5’’’ peaks
(Table IV). Furthermore, neomycin B was comparable to paromomycin in that the H-1 coupling
constant decreased upon interaction with the enzyme, but that was the only similarity between
changes in coupling constants (Table V). It is impossible to differentiate between the H-6’ peak
and H-6’’’ peak; however, the amine group adjacent to one of these protons experiences an
uptake in protons because of the increase in this coupling constant when AAC is present.
Interestingly, the 2’-amine group has the lowest pKa value other than the N-3 acetylation site,
while N-6’ and N-6’’' have the highest pKa values with N-6’’’ being slightly higher than N-6’
(Ozen et. al. 2006). Thus, for paromomycin the amine groups with the lowest pKa values
become more positively charged upon interaction with AAC3, but for neomycin the amine
groups with the lowest pKa values lose protons upon the addition of AAC3.
Table IV
Proton
H-1
H-2a
H-6
H-2’
H-1’’’
H-2’’’

Shift in 1H δ
(ppm)
0.03
0.04
0.04
0.04
0.03
0.04

Table V
Proton

Change in 1H-13C coupling constants (Hz)

H-1

-5.40

H-2’

-7.51

H-6’or
H-6’’’

+4.04

In conclusion, the amine groups of antibiotics play a key role in binding to or interacting
with AAC3 and other aminoglycoside-modifying enzymes. Other sites of particular importance
are located near the site of modification on ring 1 and on the outer rings of the aminoglycoside
on rings II and IV. This study has elucidated some of the similarities and differences in the
ligand interaction sites for an enzyme that covalently modifies and deactivates
aminoglycosides. By studying the interactions of typical aminoglycosides with AAC, it is hoped
that developments will be made to fight the growing trend of antibiotic resistance.
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